Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results May 18, 2017 Neovasc Announces Results For The Second Quarter Of 2017 August 10, 2017 All Signs Have Gilead Gearing Up for a Much-Needed Acquisition February 12, 2017
